Healthways, Inc. (NASDAQ:TVTY) – Jefferies Group cut their Q4 2017 EPS estimates for Healthways in a research report issued on Thursday. Jefferies Group analyst D. Styblo now anticipates that the company will earn $0.32 per share for the quarter, down from their previous estimate of $0.34. Jefferies Group has a “Buy” rating and a $46.00 price target on the stock. Jefferies Group also issued estimates for Healthways’ Q1 2018 earnings at $0.43 EPS, Q2 2018 earnings at $0.46 EPS, Q3 2018 earnings at $0.48 EPS and Q4 2018 earnings at $0.42 EPS.

Healthways (NASDAQ:TVTY) last released its quarterly earnings data on Thursday, October 26th. The company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.10. Healthways had a net margin of 11.45% and a return on equity of 30.23%. The business had revenue of $137.70 million during the quarter, compared to analyst estimates of $137.95 million. The business’s revenue was up 10.2% on a year-over-year basis.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this news story on another publication, it was illegally stolen and republished in violation of international copyright & trademark legislation. The original version of this news story can be viewed at https://theolympiareport.com/2017/11/01/healthways-inc-to-post-q4-2017-earnings-of-0-32-per-share-jefferies-group-forecasts-tvty.html.

A number of other research analysts also recently weighed in on TVTY. Zacks Investment Research raised shares of Healthways from a “hold” rating to a “buy” rating and set a $52.00 target price for the company in a research report on Tuesday. SunTrust Banks, Inc. set a $50.00 target price on shares of Healthways and gave the company a “buy” rating in a research report on Friday, October 27th. Chardan Capital reaffirmed a “neutral” rating and issued a $44.00 target price (up previously from $40.00) on shares of Healthways in a research report on Friday, October 27th. ValuEngine downgraded shares of Healthways from a “buy” rating to a “hold” rating in a research report on Monday, October 2nd. Finally, Barrington Research raised their target price on shares of Healthways from $35.00 to $44.00 and gave the company an “outperform” rating in a research report on Friday, July 28th. Two analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $45.25.

Healthways (NASDAQ TVTY) traded down 1.51% during midday trading on Monday, hitting $45.55. 248,311 shares of the company traded hands. Healthways has a 12-month low of $19.25 and a 12-month high of $47.90. The firm has a market capitalization of $1.79 billion, a PE ratio of 20.52 and a beta of 0.38. The stock’s 50-day moving average is $40.73 and its 200-day moving average is $37.47.

Institutional investors and hedge funds have recently made changes to their positions in the company. United Services Automobile Association bought a new position in shares of Healthways in the 1st quarter valued at about $377,000. Dimensional Fund Advisors LP bought a new position in shares of Healthways in the 1st quarter valued at about $70,660,000. Credit Suisse AG bought a new position in shares of Healthways in the 1st quarter valued at about $1,395,000. California Public Employees Retirement System bought a new position in shares of Healthways in the 1st quarter valued at about $247,000. Finally, Vanguard Group Inc. bought a new position in shares of Healthways in the 1st quarter valued at about $135,544,000.

In other news, insider Glenn Hargreaves sold 7,137 shares of Healthways stock in a transaction dated Tuesday, September 26th. The shares were sold at an average price of $40.00, for a total value of $285,480.00. Following the completion of the transaction, the insider now owns 52,180 shares of the company’s stock, valued at approximately $2,087,200. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Mary Flipse sold 14,020 shares of Healthways stock in a transaction dated Friday, August 18th. The shares were sold at an average price of $37.03, for a total transaction of $519,160.60. Following the completion of the transaction, the insider now directly owns 61,167 shares of the company’s stock, valued at approximately $2,265,014.01. The disclosure for this sale can be found here. In the last ninety days, insiders sold 74,858 shares of company stock valued at $2,847,017. 8.42% of the stock is owned by insiders.

About Healthways

Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.

Earnings History and Estimates for Healthways (NASDAQ:TVTY)

Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.